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Cord blood interleukin-8 
levels correlate with airway 
flow limitation at eight years 
of age in ex-very low birth 
weight infants
ABSTRACT
Background. Exposure to prenatal inflammation increases the risk for development of bronchopulmonary dysplasia. 
Aim. To evaluate the correlation between cord blood and gastric aspirate levels of interleukine-6 (IL-6) and interleukine-8 
(IL-8) in preterm infants, and lung function at the age of 8 years.
Methods. Between 2000-2002 we recruited 129 infants of gestational age < 30 wks. The concentration of IL-6 and IL-8 were 
measured in gastric aspirate and cord blood. At the age of 8 years, 30 ex-preterm infants, with mean gestational age of 27 
wks and mean birth weight of 955 g, returned for pulmonary function measurement. To exclude major bias, a comparison 
between the study group and non-responder group was done and showed no statistically significant difference with respect 
to perinatal characteristics, ventilation days, bronchopulmonary dysplasia and cytokine concentration. 
Results. Pulmonary function test measurments in children born preterm were lower than in their term pairs. However, only 
the difference in forced mid-expiratory flow (FEF25-75%)  was statisticaly significant.  The concentration of IL-6 and IL-8  in 
cord blood and in gastric aspirate inversely correlated to all parameters of lung fuction at the age of 8 years, however only 
correlations between the concentration of IL-8 in cord blood and forced expired volume in one second/forced vital capacity 
(FEV1/FVC) (r = -0.38, p = 0.04) and FEF 25%-75% (r = -0.44, p = 0.02) were statistically significant. 
Conclusion. These results show a negative correlation between the concentration of IL-8 in cord blood and FEF25%-75% 
and FEV1/FVC, which suggests the important role of IL-8 in early airway remodeling. 
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Introduction
The study by Watterberg et al. (1) in 
1996 established that the presence 
of chorioamnionitis (CA) is associa-
ted with a lower incidence of respira-
tory distress syndrome (RDS) and a 
higher incidence of bronchopulmonary 
dysplasia (BPD), indicating that lung 
injury can start before birth. Later stu-
dies confirmed that CA, (2,3) funisitis, 
(4) and fetal inflammatory response 
syndrome (5,6) were associated with an 
increased incidence of BPD; however, 
results were not reproduced in some 
other studies. (7,8) It has been sugge-
sted that the association between CA 
and BPD is more complicated. (9) Van 
Marter et al. (10) introduced the “mul-
tiple hit” theory. They established that 
CA does not increase the incidence of 
BPD by itself, but only in combination 
with already known risk factors for BPD, 
such as mechanical ventilation longer 
than 7 days and exposure to postna-
tal infection. In our cohort of infants, 
with gestational age (GA) < 30 weeks 
exposure to prenatal inflammation did 
not increase the risk of BPD. However, 
low gestational age, male sex, need 
for resuscitation, mechanical ventilati-
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on, and late onset sepsis were major 
risk factors for BPD development. (11) 
According to an overview from Beer 
and Zimmerman, (12) the increased 
incidence of BPD after prenatal infla-
mmation was confirmed only in 6 of 18 
studies; furthermore, in only one study 
were the results adjusted for gesta-
tional age. (13) Results of long-term 
outcomes with respect to lung functi-
on of school-age children and adoles-
cents born preterm are also conflicting. 
In some studies, respiratory function 
variables reflecting airflow were signi-
ficantly diminished (14-17) when com-
pared to healthy, term-born children 
and adolescents, while in the study by 
Narang et al. no significant difference 
was found. (15) 
The question is: can prenatal inflam-
matory exposure affect lung function in 
later life? So far, we are aware of only 
two studies investigating the associa-
tion between CA and pulmonary out-
come in childhood. (16,17) The study 
by Watterberg on children aged 18-22 
months showed no difference in the use 
of supplemental oxygen, bronchodila-
tors, and systemic or inhaled steroids 
between infants with or without CA. In 
the study by Kumar, it was established 
that CA and prematurity have a joint 
predisposing effect on recurrent whee-
zing and physician-diagnosed asthma 
at a mean age of 2.2 years.
The aim of this prospective observati-
onal study was to evaluate the effects 
of interleukin 6 (IL-6) and interleukin 8 
(IL-8) in cord blood and gastric aspirate 
on lung function 8 years after preterm 
birth.
Methods
Study design and subjects
Infants with GA < 30 wks born at the 
Ljubljana Maternity Hospital, a tertiary 
referral centre for premature infants in 
Slovenia, during the period from Sep-
tember 1st, 2000, to June 30th, 2002, 
were prospectively enrolled in the study 
with the aim to analyze prenatal and 
postnatal risk factors for the develo-
pment of BPD. The eligibility criteria 
for the study were: 1) inborn infant, 
2) written informed parental consent 
obtained, 3) cord blood and placenta 
available, and 4) absence of obvious 
congenital malformation. BPD was defi-
ned as a requirement for supplemen-
tal oxygen at 36 weeks postmenstrual 
age. (18) Details including gestational 
Figure 1. Flow-chart of the study group from birth to school age.
 GW; gestational weeks.
Figure 2. Correlation between FEF25-75% and log IL-8 concentration in cord
 blood.
 FEF25-75%, forced mid-expiratory flow; IL, interleukin.
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age, sex, birth weight, prenatal stero-
ids, and surfactant treatment, venti-
latory support and days of postnatal 
oxygen requirement were also collec-
ted. Gestational age was determined 
by the best obstetric estimate using 
the last menstrual period and/or early 
ultrasound assessment. After 8 (range 
7-9) years, children were called back 
for lung function follow-up. Infants with 
severe mental handicap were excluded 
from the follow-up (figure 1). A control 
group with 31 age and sex-matched 
children born at term was added for the 
comparison of pulmonary function tests, 
measurement of fraction of nitric oxide in 
air (FeNO), and six-minute walking test 
(6MWT). The National Medical Ethics 
Committee approved the study. Parents 
or guardians of each participating child 
gave written informed consent. 
At the time of birth, blood was collected 
from the umbilical cord, then centrifu-
ged and stored at –70oC until cytokine 
immunoassay was performed. Com-
mercial ELISA kits (Endogen-Pierce, 
Boston, USA) were used for determina-
tion of the IL-6 and IL-8 levels. Gastric 
aspirate sample was collected at the 
time of delivery with a 5F orogastric fee-
ding tube. Because no reliable correc-
tion factor was available, (19) cytokine 
concentrations in gastric aspirates were 
expressed as volume concentrations 
(pg/ml or ng/ml). The placenta, inclu-
ding fetal membranes and umbilical 
cord, was examined microscopically for 
the presence of inflammation. CA was 
Table 1. Perinatal characteristics of the study group and non-responder group. Values are expressed as a - mean 






gestational age (wks)a 26.6 (1.8) 27.2 (1.6) 0.07
birth weight (g) a 955 (254) 1041 (231) 0.05
male sex (%) 40 38 0.80
1-minute Apgar score b 6 [5-7] 6 [4-7] 0.26
5-minute Apgar score b 7 [6-8] 7 [6-8] 0.12
prenatal dexamethasone (%) 68 87 0.56
ventilation (days) c 16 (0-77) 13 (0-137) 0.39
oxygen (days) c 40 (0-162) 35 (0-149) 0.47
postnatal dexamethasone (%) 33 30 0.81
BPD (%) 33 18 0.59
IL-8 cord blood (pg/ml) b 168 [51-662] 289 [85-1017] 0.57
IL-6 cord blood (pg/ml) b 6 [1-27] 5 [2-22] 0.43
IL-8 gastric aspirate (ng/ml) b 25 [0.4-394] 22 [0.5-279] 0.25
IL-6 gastric aspirate (ng/ml) b 4 [0.1-12] 2.5 [0.4-14] 0.50
chorioamnionitis (%) 47 40 0.29
BPD, bronchopulmonary dysplasia; IL, interleukin.
Table 2.  Lung function tests at 8 years after preterm birth compared to term controls, p value for % predicted (except 
for FEV1/FVC, measured value).
preterm infants (30) term controls (31) p
measured % predicted measured % predicted
FEV 1, (L) 1.5 (0.3) 86.7 (14.5) 1.7 (0.4) 90.9 (10.5) 0.21
FVC, (L) 1.7 (0.3) 97.7 (10.8) 1.9 (0.4) 99.5 (9.8) 0.54
FEV1/FVC, (%) 82.4 (16.9) - 87 (21.0) - 0.16
FEF25-75%,  (L/s) 1.6 (0.5) 79.2 (19.6) 2.1 (0.5) 87.0 (21.0) 0.02
defined as acute when ten or more pol-
ymorphonuclear leukocytes were found 
per high-power field in the amniotic and 
chorionic membranes, in the chorionic 
plate, and/or in the umbilical cord.
61 participants attended the respiratory 
function unit at the University Children’s 
Hospital in Ljubljana for a 1.5-hour visit 
during which they were examined by 
a doctor and underwent lung function 
testing, FeNO measurement, and fitne-
ss assessments with 6MWT.
Fraction of exhaled nitric oxide
FeNO was measured following the Ame-
rican Thoracic Society/European Respi-
ratory Society’s recommendations. We 
used single breath measurement with 
computerized system device NioxMino, 
Aerocrine, Sweden, with flow rate of 
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0.05 l/min for at least 6 seconds. FeNO 
measurements were done prior to spi-
rometric manoeuvres, only in children 
without signs and symptoms of acute 
respiratory infection for 6 weeks before 
testing. We asked children not to eat or 
drink for at least 1 hour before measu-
rement. (20) Due to flow dependency 
of FeNO values, we encouraged the 
use of constant expiratory flow rates by 
using a visual computer program. Nose 
clips were not used. Three recordings 
were made. FeNO was calculated as 
the mean of three measurements with 
a coefficient of variation of less than 
10%.
Six-Minute Walk test
The fitness assessment was measured 
by 6MWT. It was chosen because it is a 
simple method for assessing exercise 
capacity. All tests were done on an 
indoor 50- m-long, flat hard ground. 
Only one technician,  trained in using 
the standard protocol,  performed all 
the tests. (21,22)    
Pulmonary Function Tests
The American Thoracic Society gui-
delines were used to perform tests. 
(23) Only one respiratory technician 
performed the measurements, and he 
was blinded to the clinical details of the 
participant. We used a flow-volume spi-
rometry (Vitalograph, Ltd, Birmingham, 
UK). The best of three manoeuvres was 
recorded. Measured variables reflec-
ting airflow were: forced expired volu-
me in one second (FEV1) and forced 
mid-expiratory flow (FEF25-75%). Lung 
volumes included forced vital capacity 
(FVC) and vital capacity (VC). Results 
were expressed as percentages of the 
standardised values predicted for nor-
mal children according to sex and hei-
ght. We used Polgar’s and Promadhat’s 
prediction equations for lung-function 
measurements. (24)
Statistical analysis
The sample size was opportunistic, so 
a power calculation was not performed. 
Numerical data are presented as mean 
± standard deviation (SD) or median 
with 1st and 3rd quartile and analyzed 
by independent-samples t-test if nor-
mally distributed, or by Mann-Whitney 
U test if skewed. Categorical data are 
expressed as proportions and analyzed 
by chi-squared or Fisher’s exact tests 
as appropriate. For post-hoc compa-
rison of categorical variables, Keppel 
modification of Bonferroni correction 
was used.
The raw data for cytokine concentra-
tions was log-transformed to obtain a 
normal distribution before correlation 
was calculated. The strength of asso-
ciation between variables was obtained 
Table 3. Characteristics of the study population at 8 years compared to term controls, results as mean (SD).
preterm infants (30) term controls (31) p
age 8.8 (0.8) 8.5 (0.5) 0.85
male sex 12 12 1.0
height (cm) 128.7 (9.7) 134.1 (10.0) 0.04
weight (kg) 27.2 (8.3) 30.4 (7.1) 0.11
eNO (ppb) 18.2 (14.2) 12.1 (4.5) 0.04
6-min WT (m) 510 (72) 525 (61) 0.39
Table 4. Correlation between measured leveles of IL-6 and IL-8 (logarithmic values) in cord blood (cb) and gastric 
aspirate (ga) at birth and lung volumes and flows at the age of 8 years. (r = Spearman`s coefficient).
IL-8cb IL-6cb IL-8ga IL-6ga 02 ventilation 






















































































by the Spearman rank-order method. 
A statistical analysis was performed 
using PASW 18 software (SPSS Inc., 
Chicago, IL, USA). A P value of < 0.05 
was considered as significant.
Results
Perinatal characteristics of the study 
group versus the non-responder pre-
term group are shown in table 1. None 
of the tested variables showed a stati-
stically significant difference between 
the groups. 
The characteristics of the study group 
at the age of 8 years are shown in table 
2 where the values are also compared 
to the term control group. Children born 
preterm were shorter at the average 
age of 8 years when compared to the 
term control group, but there was no 
difference in body weight. The values of 
pulmonary-function test measurements 
in children born preterm were lower than 
in their term pairs but only in FEF25-75% 
was the difference statistically signifi-
cant. The 6MWT showed no difference 
between both groups. The Fe-NO was 
lower in the term control group compa-
red to the preterm study group.
The concentration of IL-6 and IL-8 in 
cord blood and in gastric aspirate 
inversely correlated to all parameters 
of lung function at the age of 8 years; 
however, only the correlations between 
the concentration of IL-8 in cord blood 
to FEV1/FVC and to FEF25-75% were 
statistically significant. There was no 
correlation between the length of venti-
lator days (r = -0.012, p = 0.5)/oxygen 
treatment days (r = 0.16, p = 0.39) and 
the concentration of IL-8 in cord blood.
The length of mechanical ventilation 
was significantly inversely correlated to 
FEV1%, FVC%, and FEF25-75%, and 
the length of oxygen supplementation 
was in inverse correlation to FEV1% and 
to FEF25-75% . 
The 6MWT and FeNO at the age of 8 
yrs did not correlate either to the pre-
natal IL-8 concentration or to the length 
of respiratory support or the length of 
oxygen supplementation.
Discussion
In our study of preterm infants with GA < 
30 wks who were prospectively followed 
to the average age of 8 years, we found 
significantly lower values of FEF25-75% 
when compared to term-born controls. 
Besides the length of ventilation and 
oxygen support, the concentration of 
IL-8 in cord blood of the preterm study 
group was also associated with lower 
FEF25-75% at the age of 8 years. IL-8 
in cord blood also negatively correlated 
to FEV1/FVC at the same age.
BPD is one of the important long-term 
consequences of preterm birth. The 
length of ventilation and the length of 
oxygen treatment are well known risk 
factors for BPD. Clinical, histological, 
microbiological or biochemical CA is 
well established as a major risk fac-
tor for preterm birth. (25) The recent 
systematic review and meta-analysis of 
the association between CA and BPD 
showed that CA was significantly asso-
ciated with BPD; however, the authors 
found strong evidence of publication 
bias, and at the end they concluded 
that, despite a large body of evidence, 
CA by itself cannot be definitively con-
sidered a risk factor for BPD. However, 
in pregnancies complicated with CA 
the concentrations of IL-8 and IL-6 are 
significantly higher than in those without 
histological CA. (26,27) Ureaplasma 
spp. are the most common organisms 
isolated from amniotic fluid obtained 
from women who present with preterm 
labor either with intact membranes or 
preterm premature rupture of membra-
nes, or a short cervix associated with 
microbial invasion of the amniotic cavity. 
(26-30) Casper DC and al. found a posi-
tive correlation between the amount of 
Ureaplasma parvum and the magnitu-
de of inflammatory response inside the 
amniotic cavity observed by elevated 
IL-8 levels. (27) The production of IL-8 is 
inducible by proinflammatory cytokines 
(IL-1, tumor necrosis factor (TNF)-alp-
ha), bacteria, bacterial products, and 
viruses. Environmental conditions such 
as hypoxia also induce IL-8 formation. 
The results from our original study, from 
2000-2002, did not identify either CA 
or the cytokine level as a risk factor for 
BPD development. 
Pulmonary blood-vessel formation 
within the mesenchyme is under the 
influence of growth factors from endo-
dermal cells (VEGF) as well as some 
from within the mesenchyme (angi-
opoetin). (28) Several studies have 
examined how premature delivery and 
changes in oxygen tension, inflam-
matory cytokines, and other signals 
can decrease VEGF expression and 
signalling, thereby altering lung struc-
ture. Experimentally, hyperoxia, which 
impairs alveolar and vascular growth 
and inhibits alveolarisation in neonatal 
rats, also down-regulates lung VEGF 
and its receptors (VEGFR) expression, 
and pharmacologic inhibition of VEG-
FRs inhibits lung vascular and alveolar 
growth in newborn rats. (29,30) The 
effects of recombinant human VEGF 
165 (rh-VEGF) treatment of newborn 
rats during or after exposure to hype-
roxia on vessel growth were studied. 
Despite increased capillaries growth 
there was no positive effect on alveo-
larisation because newly formed capi-
llaries were immature and leaky, and 
led to lung edema. Despite its central 
role in vascular formation, it was shown 
that VEGF works in concert with other 
factors such as angiopoetins which 
stabilise capillaries network. (31,32) 
Accordingly, combined lung VEGF and 
angiopoetin1 gene transfer preserved 
alveolarisation and enhanced angioge-
nesis with more mature capillaries that 
were less permeable, and the vascular 
leakage seen in VEGF-induced capi-
llaries was reduced. (33) We specu-
late that the long-term effect of IL-8 in 
the new-born lung is mediated through 
abnormal vascular development which 
disables normal alveolar development. 
It is likely that vascularisation of the 
new-born lung under IL-8 stimulation 
is similar to angiogenesis described 
in tumor-producing vessels with thin 
walls, tortuous shape, absence of peri-
cytes, and variations in diameter. (34) 
As IL-8 up-regulates VEGF m-RNA in 
endothelial cells (the process requires 
activation of transcription factor NFka-
ppa and does not involve HIF1 alpha), 
the effect could be actually the same as 
in the studies where angiogenesis was 
stimulated with rh-VEGF, resulting in the
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growth of hyper-permeable capillaries 
which cannot lead to normal alveola-
risation. (35) FEF25-75% was the only 
parameter of lung-function measure-
ment which was significantly lower in the 
study group when compared to healthy 
pairs at the age of 8 years. According 
to the results of this study, it is possi-
ble that prenatal exposure to IL-8 leads 
to long-term consequences in small 
airway development. It is also interesting 
that in the sputum of adult patients with 
chronic obstructive pulmonary disease 
(COPD) the levels of VEGF, angiogenin, 
IL-8 and TNF alpha were significantly 
higher when compared to healthy smo-
kers and non-smokers. Moreover, they 
were also able to demonstrate signifi-
cant negative correlation between FEV1 
and VEGF, IL-8 and angiogenin among 
smokers. (36) It seems that IL-8, toget-
her with other angiogenic factors, plays 
an important role either in COPD or BPD 
airway remodelling.
The question has been raised whether 
or not survivors of BPD and prematurity 
have a risk of developing a COPD-like 
phenotype with aging. We are aware 
of a low number of children who res-
ponded to follow-up and also that the 
control group of term-born children did 
not have measured cytokines at birth; 
however, to the best of our knowled-
ge this data is one of the first reports 
that intrauterine inflammatory response 
could have long term consequences on 
lung function. It is likely that the long-
term effect is mediated through IL-8. 
Larger studies are necessary.
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